New 5-session radiation plan aims to ease spine tumor pain with fewer side effects

NCT ID NCT04802603

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests a new way to deliver radiation to spine tumors that have spread from other cancers. Instead of the usual 1-2 high-dose sessions, the radiation is given in 5 smaller doses over several days, which may reduce side effects. The trial will enroll 60 adults with spine metastases and measure pain relief, quality of life, and how well the treatment is tolerated.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Spine stereotactic body radiotherapy (radiation)
What this could lead to
If successful, this could offer a safer, more tolerable radiation option for people with spine tumors that have spread from other cancers, potentially reducing pain and improving daily function.
What could go wrong
This is a small, early-phase study with only 60 participants, so results may not apply to everyone. Radiation still carries risks like nerve damage or fatigue, and the approach may not work better than standard care.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for METASTASIS SPINE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Miami Cancer Institute at Baptist Health, Inc

    RECRUITING

    Miami, Florida, 33176, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.